|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.07 INR | +0.29% |
|
-7.42% | -26.42% |
| Market Cap | 976M 10.23M 8.96M 8.25M 7.66M 14.55M 14.74M 98.79M 38.45M 479M 38.42M 37.58M 1.66B | P/E 2024 |
-14.8x | P/E 2025 | -22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 1.34B 14.09M 12.34M 11.37M 10.55M 20.04M 20.31M 136M 52.95M 660M 52.92M 51.76M 2.29B | EV / Sales 2024 |
12,382,225x | EV / Sales 2025 | 14,298,457x |
| Free-Float |
21.42% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.29% | ||
| 1 week | -7.42% | ||
| Current month | -10.01% | ||
| 1 month | +26.97% | ||
| 3 months | +13.53% | ||
| 6 months | -26.31% | ||
| Current year | -26.42% |
| 1 week | 34.32 | 41.9 | |
| 1 month | 26 | 41.9 | |
| Current year | 25.6 | 50.9 | |
| 1 year | 25.6 | 70 | |
| 3 years | 25.6 | 87.46 | |
| 5 years | 10.17 | 87.46 | |
| 10 years | 2.15 | 87.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 12/10/2022 | |
| Chief Tech/Sci/R&D Officer | - | 06/08/2025 | |
| Compliance Officer | - | 13/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 04/12/2025 | |
| Director/Board Member | - | 28/08/2023 | |
| Chairman | 50 | 30/01/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.29% | -7.42% | -39.68% | -31.38% | 12.95M | ||
| -1.14% | -2.43% | +53.72% | +159.07% | 1,082B | ||
| -1.41% | +0.32% | +66.23% | +60.48% | 633B | ||
| -2.42% | +0.18% | +34.59% | +85.62% | 461B | ||
| -0.26% | +1.37% | +31.00% | +23.05% | 338B | ||
| -2.46% | -1.52% | +36.42% | +32.77% | 299B | ||
| -2.20% | -0.93% | +27.50% | +40.62% | 291B | ||
| -1.77% | +0.99% | -28.85% | -41.41% | 222B | ||
| -2.06% | +1.63% | +22.87% | +64.34% | 202B | ||
| -1.26% | +2.60% | +15.98% | +70.00% | 163B | ||
| Average | -1.47% | +3.24% | +21.98% | +46.32% | 369.24B | |
| Weighted average by Cap. | -1.55% | +5.43% | +39.61% | +79.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 151.12 1.58 1.39 1.28 1.19 2.25 2.28 15.3 5.95 74.18 5.95 5.82 257.19 | 195.14 2.05 1.79 1.65 1.53 2.91 2.95 19.75 7.69 95.78 7.68 7.51 332.1 |
| Net income | -79.68M -835K -732K -674K -625K -1.19M -1.2M -8.07M -3.14M -39.11M -3.14M -3.07M -136M | -108M -1.13M -989K -911K -846K -1.61M -1.63M -10.91M -4.25M -52.9M -4.24M -4.15M -183M |
| Net Debt | 37.29M 391K 342K 315K 293K 556K 563K 3.77M 1.47M 18.3M 1.47M 1.44M 63.46M | 368M 3.86M 3.38M 3.11M 2.89M 5.49M 5.56M 37.28M 14.51M 181M 14.5M 14.18M 627M |
Employees
28
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | ₹35.07 | +0.29% | 12,893 |
| 03/07/26 | ₹34.97 | -3.42% | 30,640 |
| 02/07/26 | ₹36.21 | -1.23% | 23,007 |
| 01/07/26 | ₹36.66 | -5.93% | 44,218 |
| 30/06/26 | ₹38.97 | +2.04% | 35,047 |
- Stock Market
- Stocks
- PHARMAID Stock
Select your edition
All financial news and data tailored to specific country editions
















